Thermo Fisher Scientific (TMO) Earns Daily Coverage Optimism Score of 0.12

News articles about Thermo Fisher Scientific (NYSE:TMO) have been trending somewhat positive on Monday, according to Accern. The research firm scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Thermo Fisher Scientific earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned media stories about the medical research company an impact score of 45.9190761868547 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

Shares of Thermo Fisher Scientific (NYSE TMO) traded up $1.51 on Monday, reaching $210.17. The company’s stock had a trading volume of 1,486,494 shares, compared to its average volume of 1,650,000. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. Thermo Fisher Scientific has a one year low of $140.00 and a one year high of $211.54. The firm has a market capitalization of $83,840.00, a price-to-earnings ratio of 35.68, a P/E/G ratio of 1.71 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same period last year, the company earned $2.03 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 13.9% compared to the same quarter last year. analysts anticipate that Thermo Fisher Scientific will post 9.36 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is currently 10.19%.

Several brokerages recently weighed in on TMO. Zacks Investment Research cut Thermo Fisher Scientific from a “hold” rating to a “sell” rating in a research report on Thursday. Deutsche Bank set a $226.00 price target on Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. BTIG Research began coverage on Thermo Fisher Scientific in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 price target for the company. Leerink Swann lifted their price target on Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a research report on Monday, October 9th. Finally, Evercore ISI began coverage on Thermo Fisher Scientific in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $212.21.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $191.74, for a total value of $9,587,000.00. Following the sale, the chief executive officer now directly owns 302,577 shares of the company’s stock, valued at $58,016,113.98. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.49% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit